Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Brand-name prescription medicine

Bloxiverz

Generic name: Neostigmine methylsulfate

FDA application holder: Exela Pharma

Official data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the NDC Directory, Drugs@FDA, the official labels and recall reports; pharmacy costs come from the Centers for Medicare & Medicaid Services (CMS). Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or switch any medicine, including a switch between a brand and a generic.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Bloxiverz?
Bloxiverz is a brand name of Neostigmine methylsulfate, a prescription medicine. The FDA NDC Directory lists 1 Bloxiverz product in 1 strength and form.
Who makes Bloxiverz?
Exela Pharma holds the FDA application for Bloxiverz (NDA204078, approved May 31, 2013).
Is there a generic or store brand of Bloxiverz?
Yes. The FDA NDC Directory lists 25 other products with the same active ingredients, strength and form as a Bloxiverz product, 25 of them generic. Ask your pharmacist whether one is right for you.
Has Bloxiverz been recalled?
No recall linked to Bloxiverz products (by their NDC code or label) appears in the FDA enforcement reports we use.

What Bloxiverz is

Each Bloxiverz product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.

Neostigmine methylsulfate · prescription medicine

Strength and formProduct namesSame medicine, other namesLabel
neostigmine methylsulfate 1 mg/mL
injection (intravenous)
Bloxiverz 25 products, 19 companies DailyMed

Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Neostigmine methylsulfate →

FDA approval

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
FDA applications of Bloxiverz products (Drugs@FDA)
ApplicationHolderFirst approvedProducts
NDA204078Exela PharmaMay 31, 20131

Companies that list Bloxiverz

The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Bloxiverz products.

Recalls

No recall linked to Bloxiverz products (by their NDC code or label) appears in the FDA enforcement reports.

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026

Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.

Report an error → · Information for medicine makers